Clinical trial
Clinical Study on Sedative Effect and Safety of Remimazolam Besylate in ARDS Patients With Mechanical Ventilation
NCT05758597 is registered in ClinicalTrials.gov with Zhiming Jiang as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Study on Sedative Effect and Safety of Remimazolam Besylate in ARDS Patients With Mechanical Ventilation
- Lead sponsor
- Zhiming Jiang
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- January 2, 2024
- Completion date
- June 16, 2025
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.